Font Size: a A A
Keyword [chronic hepatitis C]
Result: 181 - 200 | Page: 10 of 10
181. Economic Evaluation Of Direct-Acting Antivirals In The Treatment Of Chronic Hepatitis C
182. The Ultrastructural Characteristics Of The Liver With Mild,Moderate,Severe Hepatitis C And Cancerization
183. The Study On The Role Of MiR-122 In Lipid Metabolism Disorder Caused By Hepatitis C Virus Infection
184. Application of the health care system to First Nations and non-First Nations patients with chronic hepatitis C
185. Autonomic nervous system function in patients with chronic hepatitis C virus infection
186. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C
187. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection
188. Assessment of health-related quality of life in adult chronic hepatitis C patients with different categories of disease and sustained response to Intron(rtm) A
189. Clinical and economic outcomes of direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid
190. Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States
191. Ribavirin systemic and intracellular exposure and its role on viral response and anemia in chronic hepatitis c genotype 1 infectio
192. The Efficacy Of Direct-Acting Antiviral Agents In Real World And The Diseases Progression And Clinical Outcomes Of Chronic Hepatitis C With Anti-Viral Treatments
193. Epidemiological Characteristics Of Patients With Genotype 3 Hepatitis C And Efficacy And Safety Of DAAs
194. Study On The Effect Of Antiviral Therapy And Antifibrosis Therapy On Lsm Value In Patients With Chronic Hepatitis C
195. A Long-term Clinical Study Of Virological And Hepatic Benefits Of Patients With Chronic Hepatitis C Virus Infected After DAA Treatment
196. The Analysis Of Vitamin D Influencing The Outcomes Of Antiviral Therapy And The Prognosis In Patients With Chronic Hepatitis C
197. Cost-effectiveness Analysis Of Novel Direct-acting Antivirals In The Treatment Of Chronic Hepatitis C In China Based On Markov Model
198. Hepatitis C Virus In The Epidemic Of Childbearing Age Crowd And Mother-to-child Transmission (PMTCT) Survey: 5 Years Clinical Research Based On The Hospital Data
199. The Association Between Chronic Hepatitis C And Type 2 Diabetes Mellitus
200. Investigation On The Efficacy And Safety Of Sofosbuvir,Vipatavir Combined With Ribavirin In The Treatment Of Genotype 3 Chronic Hepatitis C
  <<First  <Prev  Next>  Last>>  Jump to